ribavirin has been researched along with Low Bone Density in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casado-Caballero, F; Escobar-Jimenez, F; Gonzalez-Calvin, JL; Hernandez-Quero, J; Martin-Rodriguez, JL; Redondo-Cerezo, E | 1 |
Takeda, T | 1 |
Avataneo, T; Badalamenti, S; Framarin, L; Rosina, F; Salzedo, E; Tappero, G | 1 |
1 review(s) available for ribavirin and Low Bone Density
Article | Year |
---|---|
[Progress in blood purification medicine in 2011].
Topics: Antiviral Agents; Bone Diseases, Metabolic; Cardiovascular Diseases; Chronic Disease; Hepatitis C; HIV Infections; Humans; Interferons; Kidney Diseases; Practice Guidelines as Topic; Renal Dialysis; Ribavirin | 2012 |
2 other study(ies) available for ribavirin and Low Bone Density
Article | Year |
---|---|
Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin.
Topics: Absorptiometry, Photon; Adult; Antiviral Agents; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Case-Control Studies; Drug Therapy, Combination; Female; Femur Neck; Hepatitis C, Chronic; Humans; Interferon-alpha; Lumbar Vertebrae; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Receptors, Tumor Necrosis Factor, Type I; Recombinant Proteins; Ribavirin; Tumor Necrosis Factor Decoy Receptors; Young Adult | 2014 |
Vertebral osteopenia due to bone marrow hyperplasia during interferon-alpha and ribavirin therapy for chronic hepatitis C.
Topics: Antiviral Agents; Bone Diseases, Metabolic; Bone Marrow; Hepatitis C, Chronic; Humans; Hyperplasia; Interferon alpha-2; Interferon-alpha; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Recombinant Proteins; Ribavirin | 2003 |